These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

817 related articles for article (PubMed ID: 31023337)

  • 1. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway.
    Zhang Q; Lu S; Li T; Yu L; Zhang Y; Zeng H; Qian X; Bi J; Lin Y
    J Exp Clin Cancer Res; 2019 Apr; 38(1):173. PubMed ID: 31023337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway.
    Sadremomtaz A; Mansouri K; Alemzadeh G; Safa M; Rastaghi AE; Asghari SM
    Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2688-2700. PubMed ID: 30251659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of YKL-40 inhibits angiogenesis through regulation of VEGF/VEGFR2 and ERK1/2 signaling in endometrial cancer.
    Chen HY; Zhou ZY; Luo YL; Luo Q; Fan JT
    Cell Biol Int; 2021 Dec; 45(12):2557-2566. PubMed ID: 34498339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma.
    Lin J; Cao S; Wang Y; Hu Y; Liu H; Li J; Chen J; Li P; Liu J; Wang Q; Zheng L
    J Exp Clin Cancer Res; 2018 Jun; 37(1):113. PubMed ID: 29866133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammalian Eps15 homology domain 1 potentiates angiogenesis of non-small cell lung cancer by regulating β2AR signaling.
    Wang T; Xing Y; Meng Q; Lu H; Liu W; Yan S; Song Y; Xu X; Huang J; Cui Y; Jia D; Cai L
    J Exp Clin Cancer Res; 2019 Apr; 38(1):174. PubMed ID: 31023336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Centchroman regulates breast cancer angiogenesis via inhibition of HIF-1α/VEGFR2 signalling axis.
    Dewangan J; Kaushik S; Rath SK; Balapure AK
    Life Sci; 2018 Jan; 193():9-19. PubMed ID: 29196053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA NKILA inhibited angiogenesis of breast cancer through NF-κB/IL-6 signaling pathway.
    Luo LH; Rao L; Luo LF; Chen K; Ran RZ; Liu XL
    Microvasc Res; 2020 May; 129():103968. PubMed ID: 31862380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Jun N-terminal kinase mediated VEGFR2 sustained phosphorylation is critical for VEGFA-induced angiogenesis in vitro and in vivo.
    Shen K; Ji L; Lu B; Wang Z
    Cell Biochem Biophys; 2012 Sep; 64(1):17-27. PubMed ID: 22592917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
    Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
    Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of migratory and metastatic pathways via blocking VEGFR1 and VEGFR2.
    Sadremomtaz A; Kobarfard F; Mansouri K; Mirzanejad L; Asghari SM
    J Recept Signal Transduct Res; 2018; 38(5-6):432-441. PubMed ID: 30929546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of ACE2/Ang-(1-7)/Mas axis promotes breast cancer metastasis by enhancing store-operated calcium entry.
    Yu C; Tang W; Wang Y; Shen Q; Wang B; Cai C; Meng X; Zou F
    Cancer Lett; 2016 Jul; 376(2):268-77. PubMed ID: 27063099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between VEGF and MTA1 signaling pathways contribute to aggressiveness of breast carcinoma.
    Nagaraj SR; Shilpa P; Rachaiah K; Salimath BP
    Mol Carcinog; 2015 May; 54(5):333-50. PubMed ID: 24265228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMGA2 promotes the migration and invasion of gallbladder cancer cells and HMGA2 knockdown inhibits angiogenesis via targeting VEGFA.
    Yan J; Dai P; Qin X; He Y; Zhang Y
    Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effects of Tubeimoside-1 in NCI-H1299 cells are mediated by microRNA-126-5p-induced inactivation of VEGF-A/VEGFR-2/ERK signaling pathway.
    Shi H; Bi H; Sun X; Dong H; Jiang Y; Mu H; Liu G; Kong W; Gao R; Su J
    Mol Med Rep; 2018 Mar; 17(3):4327-4336. PubMed ID: 29363720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZLM-7 inhibits the occurrence and angiogenesis of breast cancer through miR-212-3p/Sp1/VEGFA signal axis.
    Li X; Zou ZZ; Wen M; Xie YZ; Peng KJ; Luo T; Liu SY; Gu Q; Li JJ; Luo ZY
    Mol Med; 2020 Nov; 26(1):109. PubMed ID: 33187481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oleanolic Acid Inhibits Colorectal Cancer Angiogenesis by Blocking the VEGFR2 Signaling Pathway.
    Niu G; Sun L; Pei Y; Wang D
    Anticancer Agents Med Chem; 2018; 18(4):583-590. PubMed ID: 29065844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanism of inhibition of the abnormal proliferation of human umbilical vein endothelial cells by hydroxysafflor-yellow A.
    Wang J; Wang J; Wang X; Liu L; Hu J; Yu X; Xu Y; Niu X; Lin Z; Zhang Y; Zhang X; Zhang Q
    Pharm Biol; 2016 Sep; 54(9):1800-7. PubMed ID: 26730646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slit2 Promotes Angiogenic Activity Via the Robo1-VEGFR2-ERK1/2 Pathway in Both In Vivo and In Vitro Studies.
    Li S; Huang L; Sun Y; Bai Y; Yang F; Yu W; Li F; Zhang Q; Wang B; Geng JG; Li X
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5210-7. PubMed ID: 26244297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway.
    Zhong Z; Huang M; Lv M; He Y; Duan C; Zhang L; Chen J
    Cancer Lett; 2017 Sep; 403():305-317. PubMed ID: 28687357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE2 overexpression inhibits acquired platinum resistance-induced tumor angiogenesis in NSCLC.
    Cheng Q; Zhou L; Zhou J; Wan H; Li Q; Feng Y
    Oncol Rep; 2016 Sep; 36(3):1403-10. PubMed ID: 27460845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.